Menu Search
Equities

Kyorin Pharmaceutical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
KYRNF:PKL

Kyorin Pharmaceutical Co Ltd

Actions
  • Price (USD)10.47
  • Today's Change0.00 / 0.00%
  • Shares traded10.00
  • 1 Year change--
  • Beta0.2634
Data delayed at least 15 minutes, as of Mar 06 2025 13:37 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Kyorin Pharmaceutical Co Ltd, formerly Kyorin Holdings Inc, is a Japan-based company mainly engaged in the pharmaceuticals business. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The Company also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.

  • Revenue in JPY (TTM)133.26bn
  • Net income in JPY10.77bn
  • Incorporated1958
  • Employees2.00k
  • Location
    Kyorin Pharmaceutical Co Ltd8F-10F, Nikkei Bldg., 1-3-7, Ote-machiCHIYODA-KU 100-0004JapanJPN
  • Phone+81 363749700
  • Fax+81 335254780
  • Websitehttps://www.kyorin-pharm.co.jp/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.